Azimuth Capital Management’s Boston Scientific BSX Stock Holding History

Azimuth Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,600	Closed	-$208K	–	258
2019 Q4	$208K	Sell	4,600 -700	-13%	-$29.3K	0.01%	274
2019 Q3	$216K	Hold	5,300	–	–	0.01%	270
2019 Q2	$228K	Hold	5,300	–	–	0.02%	266
2019 Q1	$203K	Buy	+5,300	New	+$202K	0.01%	275
2018 Q4	–	Sell	-5,300	Closed	-$204K	–	278
2018 Q3	$204K	Buy	+5,300	New	+$185K	0.01%	281

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Azimuth Capital Management's BSX Position: Q1 2020 in Review

Azimuth Capital Management sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 4,600 shares — an estimated $208K sold.

Azimuth Capital Management first reported a position in BSX in Q3 2018 and held it in 5 quarters. The position peaked at $228K in Q2 2019. 800 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

Azimuth Capital Management reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
Azimuth Capital Management sold 4,600 Boston Scientific shares in Q1 2020, an estimated $208K.
Azimuth Capital Management first reported a position in Boston Scientific in Q3 2018 and held it in 5 quarters.
Azimuth Capital Management's Boston Scientific position peaked at $228K in Q2 2019.
800 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Azimuth Capital Management's 13F filing for Q1 2020, filed 13 May 2020.